Group A
Group B
Group C
Group D
100

A common first-line treatment for Major Depression Disorder.

SSRI, SNRI

100

A common first-line treatment for generalized anxiety disorder. 

SSRI, SNRI

100

Lab test monitored frequently in patients who are taking clozapine (Clozaril).

WBC

100

Treatment of choice for benzodiazepine intoxication.

Flumazenil

200

A depression screening tool.

PHQ-9

200

Worrying that cannot be controlled for the last six months.

GAD

200

Average treatment with ECT.

7-8 treatments are administered over a 2- to 3-week period

200

Lab test checked routinely in patients taking lithium.

TSH

300

Fear of open spaces, crowded places and places from which escape seems difficult.

Agoraphobia

300

Mood stabilizer medication

Lithium

300

Generalized anxiety disorder screening assessment

GAD-7

300

Known also as manic-depression.

Bipolar I

400

Mood lability, irritability, dysphoria, and anxiety that occur repeatedly during premenstrual phase of the menstruation cycle.

Premenstrual Dysphoric Disorder

400

First line treatment for Bipolar I disorder

Atypical antipsychotic

400

Depressed mood for the majority of time most days for at least 2 years (in children or adolescents for at least 1 year)

Dysthymia, Dysthymic disorder

400

A chronic depression (less severe form of major depression) for a minimum period of 2 years.

Persistent depressive disorder

500

Fear of needles. 

Trypanophobia

500

Chronic, recurrent disorder that lasts for at least 2 years in which there are oscillations between dysthymia and hypomania.

Cyclothymic disorder

500

Chronic, severe, persistent irritability occurring in childhood and adolescence; Occurs with males more than females.

Disruptive mood dysregulation disorder

500

Disorder needing higher doses of SSRIs as initial treatment. 

OCD

M
e
n
u